Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000679605 | SCV000531625 | likely benign | not provided | 2018-12-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679605 | SCV000806728 | likely benign | not provided | 2018-01-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000679605 | SCV002231153 | likely benign | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001356095 | SCV001551163 | likely benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The POLE c.1795-13G>A variant was not identified in the literature. The variant was identified in dbSNP (rs749522265) as “with likely benign allele”, ClinVar (interpreted as "likely benign" by GeneDx and Prevention Genetics). The variant was identified in control databases in 2 of 245,234 chromosomes at a frequency of 0.000008 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Latino in 2 of 33,502 chromosomes (freq: 0.00006), but not in the African, Other, European, Ashkenazi Jewish, East Asian, Finnish, and South Asian populations. The variant occurs at a non-conserved nucleotide outside of the consensus splicing sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |